about
Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma.Prognostic significance of serum immunoglobulin paraprotein in patients with diffuse large B cell lymphoma.Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia.Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases.Low serum cholesterol levels predict inferior prognosis and improve NCCN-IPI scoring in diffuse large B cell lymphomaDA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphomaNDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemiaThe percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia without treatment indicationCirculating tumor DNA: clinical roles in diffuse large B cell lymphomaDefinition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variablesThe prognostic role of HBV infection in chronic lymphocytic leukemiaHyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphomaInterim response in diffuse large B cell lymphoma on CT: what is the optimal size reduction (ΔSPD) for predicting outcome?Circ-RPL15: a plasma circular RNA as novel oncogenic driver to promote progression of chronic lymphocytic leukemiaA new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia25-Hydroxy vitamin D deficiency predicts inferior prognosis in mantle cell lymphomaThe impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaAssociation of red blood cell distribution width and outcomes in patients with mantle cell lymphoma
P50
Q40355952-6F835B4C-BFE8-4902-B954-F4C39D8A9D52Q48159217-5689A4DD-992D-4F3E-8466-000E55FC4E31Q48312107-792DC885-F57A-4F45-AC99-50C16C657262Q49850670-9CBDF3F6-5F9E-412E-8667-2A54A78386C6Q52638918-9D3E5F3E-623C-4903-A36E-0BD88D7E390DQ57131670-4E20360A-18AE-40F7-A7B2-3C8CA57AE9EDQ57458066-74DD2B5D-8AB3-453D-98CE-C52713549E0CQ57801351-712AACC3-0AC4-4B0B-BC04-50B73D0D0E3DQ57802917-D9582B73-0FF8-4A31-AEAD-5C699FB0CE01Q58109838-F57A87B1-6CE9-4C58-80BA-F43913E45A32Q59358761-678DFF84-5229-439D-B0F9-2C6FC03463DDQ59360923-1CDC1E37-650A-4E55-BAA7-29DE217BCE44Q88961812-AA2535E6-D9B3-4300-AF15-4DE0C31FBECAQ89741725-4DAC1BB8-8C33-4629-8C6D-DC5B6680F2ADQ90703603-9EFCEEF8-98B7-4B10-85B3-404986D83585Q91406112-8EF4FA7D-362E-401C-8E61-E226A42E4978Q92066176-ACA59D64-B111-4F25-9609-5623F789BB2EQ92506940-1DA3B1D8-E990-4C4A-A26E-AD050C172A90Q92670077-AA39FCDD-F32B-440B-8CF0-E621B5290D34Q93068914-39ED5C8F-9F55-4A6F-B50E-041F9C746EB1
P50
description
researcher (ORCID 0000-0003-4208-7477)
@en
wetenschapper
@nl
name
Wei Xu
@en
Wei Xu
@nl
type
label
Wei Xu
@en
Wei Xu
@nl
prefLabel
Wei Xu
@en
Wei Xu
@nl
P31
P496
0000-0003-4208-7477